Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed in the Phase 3 registration study of TLX591-Px (Illuccix®, Kit for the preparation ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) today announces that the first patient in the United States (U ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

A popular over-the-counter supplement that patients with cancer are prescribed or buy on their own to improve hair and nail ...